Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Market Cap ($5.95 Million)
Market Cap & Net Worth: Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD)
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares market cap. Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (NASDAQ:HKPD) has a market capitalization of $5.95 Million ($5.95 Million) as of November 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #28168 globally and #5805 in its home market, demonstrating a 1730.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's stock price $1.83 by its total outstanding shares 42167457 (42.17 Million). Also see how efficiently does Hong Kong Pharma Digital Technology Hold generate cash for how efficiently the company converts equity into cash flow.
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Market Cap History (2025–2026)
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares market cap history from 2025 to 2026. Data shows change from $34.76 Million to $77.17 Million (-19.32% CAGR). Check HKPD stock price for real-time trading data and today's change.
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Hong Kong Pharma Digital Technology Hold (HKPD) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
5.74x
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's market cap is 5.74 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $34.76 Million | $20.31 Million | -$27.06K | 1.71x | N/A |
| 2026 | $77.17 Million | $13.43 Million | -$1.14 Million | 5.74x | N/A |
Competitor Companies of HKPD by Market Capitalization
Companies near Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares in the global market cap rankings as of November 3, 2026. Also see Hong Kong Pharma Digital Technology Hold assets under control for a full breakdown of the balance sheet.
Key companies related to Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #247 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #450 globally with a market cap of $61.32 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #625 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1151 globally with a market cap of $22.38 Billion USD ( AU$31.63 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #247 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $998.38 |
| #450 | Cencora Inc. | NYSE:COR | $61.32 Billion | $337.84 |
| #625 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $254.33 |
| #1151 | Sigma Healthcare Ltd | AU:SIG | $22.38 Billion | AU$2.74 |
Market Capitalization of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (2025–2026)
Market capitalization of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares from 2025 to today. Between 2025 and today, Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's market cap moved from $34.76 Million to $ 77.17 Million, with a yearly change of -19.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $77.17 Million | +121.98% |
| 2025 | $34.76 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.95 Million USD |
| MoneyControl | $5.95 Million USD |
| MarketWatch | $5.95 Million USD |
| marketcap.company | $5.95 Million USD |
| Reuters | $5.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides valu… Read more